<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04830254</url>
  </required_header>
  <id_info>
    <org_study_id>TENS21</org_study_id>
    <nct_id>NCT04830254</nct_id>
  </id_info>
  <brief_title>Correlation Between Selected Haematological and Doppler Ultrasonic Parameters in Peripheral Arterial Diseased Patients</brief_title>
  <official_title>Correlation Between Selected Hematological and Doppler Ultrasonic Parameters After Electrical Stimulation in Peripheral Arterial Diseased Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Forty patients of both sexes, aged between 50 and 60 years, were chosen from an outpatient&#xD;
      vascular clinic in the El Sahel Education Hospital. Patients have been examined and referred&#xD;
      to by a vascular specialist.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The participants were divided randomly into two groups of equal numbers. The study group got&#xD;
      low-frequency TENS (4 Hz frequency, pulse duration 200 μs) which was administered through&#xD;
      surface electrodes for 45 min per session, supramaximal stimulation for T12, L1, and L2&#xD;
      sympathetic ganglions that innervate the lower extremity for 45 min per session, three times&#xD;
      per week and for 12 weeks. Control Group that received placebo stimulation as provided by the&#xD;
      same TENS device but with a zero volt after 10 s of stimulation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 20, 2021</start_date>
  <completion_date type="Actual">May 20, 2021</completion_date>
  <primary_completion_date type="Actual">May 12, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Red cell distribution width (RDW)</measure>
    <time_frame>change from baseline to after 12 weeks</time_frame>
    <description>Peripheral venous blood samples were obtained from each patient.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean platelet volume(MPV)</measure>
    <time_frame>change from baseline to after 12 weeks</time_frame>
    <description>Peripheral venous blood samples were obtained from each patient.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ankle peak systolic velocity (APSV)</measure>
    <time_frame>change from baseline to after 12 weeks</time_frame>
    <description>is the mean of the peak systolic velocities of the anterior and posterior tibial arteries measured at the ankle level by doppler ultrasonography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Arterial diameter</measure>
    <time_frame>change from baseline to after 12 weeks</time_frame>
    <description>Diameter of lower limb arteries measured by doppler ultrasonography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Actual claudication distance</measure>
    <time_frame>change from baseline to after 12 weeks</time_frame>
    <description>Claudication pain distance was measured after running on a treadmill constant walking speed of 2 mile/hour at 0% grade, with gradual increases in grade of 2.0% every 2 minutes.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Peripheral Arterial Disease</condition>
  <arm_group>
    <arm_group_label>study group(A)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group (A) included 20 patients who received low-frequency TENS (frequency 4 Hz, pulse duration 200 μs) for 45 min per session, three times per week, and for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group(B)</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>The control group(B) included 20 patients who received placebo TENS stimulation but with a voltage level falling to zero after 10 s of stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcutaneous Electrical Nerve Stimulation(TENS) device</intervention_name>
    <description>The Patients in group (A) received low-frequency TENS (frequency 4 Hz, pulse duration 200 μs,burst mode) was be applied through 2 output channels surface electrodes with an E2 TENS device, for 45 min per session, supramaximal stimulation to sympathetic ganglions in T12, L1, and L2, which innervate the lower extremity . For 45 min per session, three times per week, and for 12 weeks.</description>
    <arm_group_label>Control group(B)</arm_group_label>
    <arm_group_label>study group(A)</arm_group_label>
    <other_name>TENS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Unilateral Leriche-Fontaine stage-II PAD&#xD;
&#xD;
          2. Both sexes&#xD;
&#xD;
          3. Aged 50 to 60 years&#xD;
&#xD;
          4. Outpatients&#xD;
&#xD;
          5. Clinically stable&#xD;
&#xD;
          6. Sedentary&#xD;
&#xD;
          7. Not participating in any physical activity last 3 months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Walking disorders related to orthopedic or neuromuscular disease&#xD;
&#xD;
          2. Renal insufficiency requiring dialysis (Renal diseases)&#xD;
&#xD;
          3. Known and documented myopathy&#xD;
&#xD;
          4. Progressive cancer&#xD;
&#xD;
          5. Associated progressive disease causing a deterioration in general health&#xD;
&#xD;
          6. Participation in another research protocol&#xD;
&#xD;
          7. Skin disorder making it impossible to use TENS&#xD;
&#xD;
          8. Absolute contraindication to physical activity&#xD;
&#xD;
          9. Presence of a pacemaker/defibrillator&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Faculty of Physical Therapy</name>
      <address>
        <city>Cairo</city>
        <zip>12316</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>March 31, 2021</study_first_submitted>
  <study_first_submitted_qc>March 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 5, 2021</study_first_posted>
  <last_update_submitted>July 26, 2021</last_update_submitted>
  <last_update_submitted_qc>July 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Heba Ahmed Ali Abdeen</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

